Cargando…

Analgesic effect of a mixed T-type channel inhibitor/CB(2) receptor agonist

BACKGROUND: Cannabinoid receptors and T-type calcium channels are potential targets for treating pain. Here we report on the design, synthesis and analgesic properties of a new mixed cannabinoid/T-type channel ligand, NMP-181. RESULTS: NMP-181 action on CB(1) and CB(2) receptors was characterized in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadotti, Vinicius M, You, Haitao, Petrov, Ravil R, Berger, N Daniel, Diaz, Philippe, Zamponi, Gerald W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703287/ https://www.ncbi.nlm.nih.gov/pubmed/23815854 http://dx.doi.org/10.1186/1744-8069-9-32

Ejemplares similares

Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands
por: You, Haitao, et al.
Publicado: (2011)

NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors
por: Berger, N Daniel, et al.
Publicado: (2014)

Characterization of Novel Cannabinoid Based T-Type Calcium Channel Blockers with Analgesic Effects
por: Bladen, Chris, et al.
Publicado: (2014)

Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties
por: Pudukulatham, Zubaidha, et al.
Publicado: (2016)

Analgesic effects of optogenetic inhibition of basolateral amygdala inputs into the prefrontal cortex in nerve injured female mice
por: Gadotti, Vinicius M., et al.
Publicado: (2019)

The terpenes camphene and alpha-bisabolol inhibit inflammatory and neuropathic pain via Cav3.2 T-type calcium channels
por: Gadotti, Vinicius M., et al.
Publicado: (2021)

Cav3.2 T-type calcium channels control acute itch in mice
por: Gadotti, Vinicius M., et al.
Publicado: (2020)

Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels
por: Gadotti, Vinicius de Maria, et al.
Publicado: (2023)

Cellular prion protein protects from inflammatory and neuropathic pain
por: Gadotti, Vinicius M, et al.
Publicado: (2011)

Disrupting USP5/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation
por: Gadotti, Vinicius M., et al.
Publicado: (2018)

Anxiolytic effects of the flavonoid luteolin in a mouse model of acute colitis
por: Gadotti, Vinicius M., et al.
Publicado: (2019)

Ethosuximide inhibits acute histamine- and chloroquine-induced scratching behavior in mice
por: Gadotti, Vinicius M., et al.
Publicado: (2021)

The IL33 receptor ST2 contributes to mechanical hypersensitivity in mice with neuropathic pain
por: Huang, Junting, et al.
Publicado: (2021)

All roads lead to presynaptic calcium channel inhibition by the ghrelin receptor: Separate agonist-dependent and -independent signaling pathways
por: Weiss, Norbert, et al.
Publicado: (2015)

Antihyperalgesic effect of joint mobilization requires Cav3.2 calcium channels
por: Martins, Daniel F., et al.
Publicado: (2023)

A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain
por: Garcia-Caballero, Agustin, et al.
Publicado: (2016)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Time-Dependent Protection of CB2 Receptor Agonist in Stroke
por: Yu, Seong-Jin, et al.
Publicado: (2015)

Evaluation of carboxamide-type synthetic cannabinoids as CB(1)/CB(2) receptor agonists: difference between the enantiomers
por: Doi, Takahiro, et al.
Publicado: (2017)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain
por: Gadotti, Vinicius M, et al.
Publicado: (2015)

The Role of BK Channels in Antiseizure Action of the CB1 Receptor Agonist ACEA in Maximal Electroshock and Pentylenetetrazole Models of Seizure in Mice
por: Asaadi, Sina, et al.
Publicado: (2017)

Novel TRPV1 Channel Agonists With Faster and More Potent Analgesic Properties Than Capsaicin
por: Duarte, Yorley, et al.
Publicado: (2020)

Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor
por: Scott, Caitlin E., et al.
Publicado: (2015)

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy
por: Zhu, Yanjing, et al.
Publicado: (2023)

Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist
por: Rizzi, Anna, et al.
Publicado: (2016)

Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway
por: Yang, Shuai, et al.
Publicado: (2020)

Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB(2) Receptor
por: Taylor, Lewis, et al.
Publicado: (2015)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020)

Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021)

Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)

Effects of the cannabinoid CB(1) agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
por: Berger, Joel I., et al.
Publicado: (2017)

Trafficking of neuronal calcium channels
por: Weiss, Norbert, et al.
Publicado: (2017)

Analgesic Effects of Different κ-Receptor Agonists Used in Daytime Laparoscopic Cholecystectomy
por: Zhou, Wanjun, et al.
Publicado: (2021)

Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
por: Verty, A. N. A., et al.
Publicado: (2015)

Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2–USP5 interactions in the pain pathway
por: Stemkowski, Patrick L, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1mg3mm1vl8tcvau59fue51juu1